.png){kind=icon}
返回
Multiple System Atrophy: Recent Developments and Future Perspectives
.png){kind=icon}
PRE
AI
DOI：10.1002/mds.27894.png)
.png){kind=icon}
.png){kind=icon}
分享.png){kind=icon}
收藏
摘要
En 中文
Multiple system atrophy (MSA) is a rare and fatal neurodegenerative disorder characterized by a variable combination of parkinsonism, cerebellar impairment, and autonomic dysfunction. The pathologic hallmark is the accumulation of aggregated alpha-synuclein in oligodendrocytes, forming glial cytoplasmic inclusions, which qualifies MSA as a synucleinopathy together with Parkinson's disease and dementia with Lewy bodies. The underlying pathogenesis is still not well understood. Some symptomatic treatments are available, whereas neuroprotection remains an urgent unmet treatment need. In this review, we critically appraise significant developments of the past decade with emphasis on pathogenesis, diagnosis, prognosis, and treatment development. We further discuss unsolved questions and highlight some perspectives. (c) 2019 International Parkinson and Movement Disorder Society
Keyword:
diagnosis
MSA
prognosis
treatment
alpha-synuclein
AI总结
对已上传原文的论文进行重点信息的提取，主要内容包括：简要概述、研究摘要、背景介绍、关键亮点、图文解析、展望与总结。
期刊
IF:
7.6
论文数:
1.1W
被引数:
3.9W
机构
引用论文
Novel cyclic azobenzene-containing vesicles: photo/reductant responsiveness and potential applications in colon disease treatment.png)
RSC Advances
RSC AdvancesIF0
PREAI
分享收藏Cerebral blood flow and cerebrovascular CO
2
reactivity in stroke‐age normal controlsNeurology
NeurologyIF0
PREAI
分享收藏Alpha-Synuclein Expression in the Oligodendrocyte Lineage: an In Vitro and In Vivo Study Using Rodent and Human ModelsSTEM CELL REPORTS
OAAI
STEM CELL REPORTSIF5.1
OAAI分享收藏Identification and Quantification of Oligodendrocyte Precursor Cells in Multiple System Atrophy, Progressive Supranuclear Palsy and Parkinson's DiseaseBRAIN PATHOLOGYOAAI
BRAIN PATHOLOGYIF6.2
OAAI分享收藏MRI supervised and unsupervised classification of Parkinson's disease and multiple system atrophyMOVEMENT DISORDERS
MOVEMENT DISORDERSIF7.6
PREAI
分享收藏Distinctive distribution of phospho-alpha-synuclein in dermal nerves in multiple system atrophyMOVEMENT DISORDERS
MOVEMENT DISORDERSIF7.6
PREAI
分享收藏Safety and tolerability of growth hormone therapy in multiple system atrophy: A double-blind, placebo-controlled studyMOVEMENT DISORDERS
OAAI
MOVEMENT DISORDERSIF7.6
OAAI分享收藏Survival of patients with pathologically proven multiple system atrophy: A meta-analysisNEUROLOGY
NEUROLOGYIF8.5
PREAI
分享收藏
查看更多内容